ifmagic glp 1 reviews and complaints GLP-1 receptor agonists are increasingly used to treat type 2 diabetes obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read Scam weight-loss drops marketed to

It does not mean the medication has stopped working entirely

31,35-37 Prospective trials are needed to further explore this potential adverse event and worsened DR, which is the central premise of the ophthalmic FOCUS trial that is expected to release results in 2026

Providers can also adjust dosages to optimize outcomes and minimize side effects

By comparison, Mounjaros pivotal SURMOUNT-1 trial reported up to around 22.5% mean weight loss at 72 weeks, and Wegovys STEP-1 trial reported around 14.9% at 68 weeks

Eden also offers a 10% weight loss guarantee within 6 months for patients who follow the program and do not hit the tartget, you may qualify for a refund under program guidelines